BioRem Inc. (TSXV:BRM)
Canada
· Delayed Price · Currency is CAD 3.300
+0.060 (1.85%)
Apr 28, 2026, 3:57 PM EST
BioRem Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 42.36 | 37.42 | 25.17 | 28.86 | 24.48 | Upgrade
|
| Revenue Growth (YoY) | 13.19% | 48.69% | -12.81% | 17.91% | 0.42% | Upgrade
|
| Cost of Revenue | 29.59 | 27.36 | 18.14 | 20.1 | 18.24 | Upgrade
|
| Gross Profit | 12.77 | 10.06 | 7.02 | 8.76 | 6.24 | Upgrade
|
| Selling, General & Admin | 6.14 | 5.62 | 3.91 | 5.79 | 3.91 | Upgrade
|
| Research & Development | 0.05 | 0.04 | 0.03 | 0.1 | 0.01 | Upgrade
|
| Other Operating Expenses | - | - | - | 0 | -0.03 | Upgrade
|
| Operating Expenses | 6.19 | 5.66 | 3.94 | 5.88 | 3.9 | Upgrade
|
| Operating Income | 6.57 | 4.39 | 3.09 | 2.88 | 2.33 | Upgrade
|
| Interest Expense | -0.16 | -0.19 | -0.27 | -0.26 | -0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.08 | -0.05 | -0.02 | -0.24 | -0.26 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 6.33 | 4.15 | 2.79 | 2.38 | 2.03 | Upgrade
|
| Pretax Income | 6.33 | 4.15 | 2.79 | 2.38 | 2.03 | Upgrade
|
| Income Tax Expense | 1.51 | 1.1 | 0.61 | 0.77 | 0.74 | Upgrade
|
| Net Income | 4.82 | 3.04 | 2.18 | 1.61 | 1.3 | Upgrade
|
| Net Income to Common | 4.82 | 3.04 | 2.18 | 1.61 | 1.3 | Upgrade
|
| Net Income Growth | 58.25% | 39.66% | 35.11% | 24.34% | -37.89% | Upgrade
|
| Shares Outstanding (Basic) | 16 | 16 | 16 | 15 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 19 | 19 | 16 | 18 | 37 | Upgrade
|
| Shares Change (YoY) | -0.40% | 19.41% | -10.72% | -53.08% | -5.32% | Upgrade
|
| EPS (Basic) | 0.30 | 0.19 | 0.14 | 0.10 | 0.04 | Upgrade
|
| EPS (Diluted) | 0.26 | 0.16 | 0.13 | 0.09 | 0.04 | Upgrade
|
| EPS Growth | 62.50% | 23.08% | 44.45% | 149.20% | -27.77% | Upgrade
|
| Free Cash Flow | 7.27 | 3.31 | -0.06 | 1.24 | 3.71 | Upgrade
|
| Free Cash Flow Per Share | 0.39 | 0.18 | -0.00 | 0.07 | 0.10 | Upgrade
|
| Gross Margin | 30.14% | 26.87% | 27.90% | 30.36% | 25.48% | Upgrade
|
| Operating Margin | 15.52% | 11.74% | 12.26% | 9.97% | 9.54% | Upgrade
|
| Profit Margin | 11.37% | 8.13% | 8.66% | 5.59% | 5.30% | Upgrade
|
| Free Cash Flow Margin | 17.17% | 8.85% | -0.25% | 4.30% | 15.14% | Upgrade
|
| EBITDA | 6.91 | 4.67 | 3.28 | 3 | 2.49 | Upgrade
|
| EBITDA Margin | 16.31% | 12.49% | 13.03% | 10.38% | 10.16% | Upgrade
|
| D&A For EBITDA | 0.33 | 0.28 | 0.19 | 0.12 | 0.15 | Upgrade
|
| EBIT | 6.57 | 4.39 | 3.09 | 2.88 | 2.33 | Upgrade
|
| EBIT Margin | 15.52% | 11.74% | 12.26% | 9.97% | 9.54% | Upgrade
|
| Effective Tax Rate | 23.89% | 26.63% | 21.86% | 32.32% | 36.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.